Made Scientific, Inc., a U.S.-based clinical and commercial cell therapy contract development and manufacturing organization (CDMO), and RoosterBio, Inc., a leading supplier of human mesenchymal stem cells (MSCs), engineered bioprocess media, and bioprocess development services, announced a strategic partnership integ…
Alcami Corporation, a leading U.S.-based contract development and manufacturing organization (CDMO), announced the completion of the acquisition of Tjoapack, a leading global contract packaging organization with facilities in the United States and The Netherlands. The combined organization now employs over 1,400 skil…
Lunai Bioworks, has completed a $20 million preferred equity issuance to acquire intellectual property assets from two counterparties, strengthening its central nervous system (CNS) platform with new neurotherapeutic compounds and delivery technologies. The acquisition is designed to address a key challenge in neurolo…
Huahui Health announced that it has entered into a global exclusive option, license and collaboration agreement with BeOne Medicines for HH160, a novel trispecific antibody in oncology immunotherapy. Under the agreement, BeOne Medicines is granted an exclusive option covering the development, manufacturing, and commer…
PerZeption is set to present new data validating its AIM+ CSF modeling technology at the Association of Research in Vision and Ophthalmology (ARVO) annual meeting. "We are very excited to collaborate with Alcon, one of the largest companies within the Ophthalmology sector worldwide. ", Dr. Jan Skerswetat said. "The r…
CellProthera announces a new collaboration to optimize manufacturing processes using Quintessence’s technology, preparing its cell therapy to advance into clinical trials for the treatment of ischemic stroke. Quintessence Biotech, a developer of cell processing technologies, has completed proof-of-concept testing for …
Azra AI, the leading end-to-end enterprise platform for incidental findings and oncology workflow automation, announced the acquisition of Thynk Health, the specialized leader of lung cancer screening and incidental findings management. The deal unites two of healthcare's most trusted names in imaging-driven care coor…
Eli Lilly and Company and Ajax Therapeutics, Inc. , a biopharmaceutical company developing next generation JAK inhibitors for patients with myeloproliferative neoplasms (MPNs), announced a definitive agreement for Lilly to acquire Ajax. Ajax's lead asset, AJ1-11095, is an investigational, once-daily oral, first-in-cla…
BioMarin Pharmaceutical Inc. said that it completed the previously announced agreement to acquire Amicus Therapeutics for $14.50 per share in an all-cash transaction for a total equity value of approximately $4.8 billion. "The completion of the Amicus acquisition advances BioMarin's strategy to strengthen and divers…
IMG Pharmaceutical Co., Ltd., a majority-owned subsidiary of IMG Japan, the Group's holding company, announced that it has entered into a definitive agreement to acquire Matsumoto Pharmaceutical Co., Ltd., a Japanese pharmaceutical manufacturer. IMG Medical Group operates an integrated healthcare platform across Asi…
Page 9 of 36